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Jennifer Gardy1, Nicholas J. Loman2* and Andrew Rambaut3Abstract
It is time to shake up public health surveillance. New
technologies for sequencing, aided by friction-free
approaches to data sharing, could have an impact on
public health efforts.
Keywords: Ebola, Real-time whole-genome
sequencing, Surveillance, Salmonellabiting discernable nucleotide differences over time-scales
of weeks to months — differences that can be used toBackground
Zoonotic pathogens have serious consequences for hu-
man health. A single transmission of a virus — plausibly
from a bat to a boy playing by an old, dead tree [1] —
has led to the largest outbreak of Ebola virus disease
ever, claiming over 11,000 lives in West Africa [2]. Simi-
larly, the MERS coronavirus, seemingly endemic in
dromedary camels in the Arabian Peninsula [3], has re-
peatedly spilled over to humans, causing numerous out-
breaks — the latest involves hundreds of patients in
South Korea and China and arose from a single infected
traveller. In 2009, a new lineage of swine H1N1 influ-
enza emerged in North America into humans, creating
the first pandemic of the 21st century and establishing a
new seasonal lineage of influenza A virus. Over a million
cases of Salmonella infection occur in the USA each
year [4], and, when outbreaks are large enough to
warrant investigation, they are often linked to sources of
food production.The need for pathogen genomic surveillance
Controlling potentially lethal pathogens requires timely,
comprehensive surveillance systems. These systems cur-
rently rely on case counting and simple genotyping tech-
niques, but surveillance could be markedly improved
through genomics. Pathogen sequencing has commonly* Correspondence: n.j.loman@bham.ac.uk
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classification into ‘genotypes’ (genetic lineages) that can be
associated with host species or geographical regions. More
recently, however, genome sequencing has emerged as a
crucial tool in our real-time response to outbreaks of infec-
tious disease.
Many pathogens causing acute disease evolve rapidly,
with genomes from even closely linked cases often exhi-
draw informative epidemiological conclusions. Initial
genetic sequencing of a newly emerging virus can pro-
vide a substantial amount of information about the na-
ture of the pathogen through comparison with existing
sequences. As more cases are sequenced, analysis of the
genetic diversity among the population can provide esti-
mates of how fast the disease is spreading and help pre-
dict its future course. In the early stages of the 2009
H1N1 influenza A pandemic, a sequence-based estimate
of the transmission potential was shown to be compar-
able to a traditional epidemiological estimate, providing
the first characterization of the epidemiology of the new
human epidemic [5]. Sequencing of bacterial pathogens
has also proved useful in understanding and managing
acute outbreaks in hospital and community settings.Real-time genomic epidemiology: a new
opportunity
Such progress is remarkable, but we are now on the
cusp of a second revolution in genomic epidemiology.
The potential exists to move from pathogen genomics
providing static ‘snapshots’ of epidemics, often months
after the cases occurred, to a situation where data are
produced in real-time, providing a detailed picture of
the epidemic that is only a few days old. The advance
of high-throughput sequencing means that it is pos-
sible to obtain whole-genome sequences from clinical
samples within days. Now, genomic epidemiologists
are working to bring sequencing to the outbreak, ra-
ther than sending isolates to a reference laboratory.icle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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intervene in an outbreak rather than simply document
it in retrospect. For such applications, the useful half-
life of genomic information for epidemiology, while
there is a chance to influence control practices, can be
measured in days or weeks.
Benchtop sequencing technologies and, most recently,
portable nanopore sequencing are making cheap, close-
to-the-sample sequencing a reality. One of us (NJL) re-
cently showed that the Oxford Nanopore MinION can
be used for real-time detection of Salmonella enterica
from clinical isolates during the investigation of a large
hospital outbreak [6]. Others have used this system for
metagenomics diagnosis of viral infections directly from
clinical samples [7].
Sharing and comparing
No matter how rapidly they are generated, pathogen
genome sequences are of limited utility when viewed in
isolation. They must be examined in the context of a
constantly updating database of comparator strains and
the associated epidemiological and surveillance data.
This can be seen in the S. enterica hospital outbreak. Ini-
tially, genome sequencing demonstrated that the out-
break was of a single strain, but could not identify its
origins. When the genome data were integrated with na-
tional surveillance data, the cases were linked to a larger,
national outbreak. Later, when the UK data were com-
pared with European sequences, a link to a larger, con-
tinental outbreak became apparent and was traced to an
egg production factory [2]. Sharing in this case was ad
hoc — sequences generated during the outbreak were
shared through the file-sharing utility Dropbox (http://
www.dropbox.com) with Public Health England, who
were then able to integrate the genomic data with their
national surveillance database. Indeed, the modern inter-
net sharing era is ideally suited for such digital pathogen
surveillance data. Cloud services, such as Google Drive
(http://drive.google.com) and Dropbox, facilitate rapid
data sharing between engaged parties, while collabora-
tive tools, such as GitHub (http://www.github.com) and
the Slack communication platform (http://www.slackhq.
com), make it easy for international teams to write to an
‘open lab notebook’ [8]. Online tools can provide power-
ful evolutionary and epidemiological visualizations, such
as Bedford and Nehrer’s nextflu, which was originally
designed for influenza strain tracking and has now been
adapted to integrate real-time Ebola genomic datasets
(http://ebola.nextflu.org) [9]. We have also employed the
Microreact website (http://microreact.org) to integrate
phylogenetic and geographical information into an easy-
to-use website for epidemiologists engaged in the Ebola
outbreak response [10].Into the field
Real-time genomic surveillance can also be performed in
resource-limited settings. Since April 2015, we have been
engaged in genomic surveillance of the ongoing out-
break of Ebola virus in West Africa. Under the auspices
of the European Mobile Laboratories in Guinea, we have
successfully used nanopore sequencing to cluster cases
based on their genome sequence. These clusters are
available within a few days after diagnosis and can be
used by epidemiologists to investigate chains of trans-
mission. Another group, based at the University of
Cambridge, UK, have been providing similar information
generated on the Ion Torrent platform in real-time from
Sierra Leone. Integration of the most-recent datasets
showed that contemporary cases in Guinea cluster with
cases in Sierra Leone, strongly suggestive of cross-
border transmissions [11].
Such ad hoc international collaborations seem to
arise naturally in the context of urgent public health
investigations, where there is strong pressure to re-
lease data and a community of researchers ready to
engage (see also the Escherichia coli O104:H4 out-
break in Germany, where crowd-sourced analysis was
carried out by researchers on four continents) [12].
However, challenges exist in standardizing and scaling
this model for routine pathogen surveillance. Such
activities are typically performed under the purview
of government-funded surveillance laboratories. Al-
though there are good arguments that agencies should
share their data widely and openly, there are concerns
about negative side effects. Many objections center
around how potentially identifying ‘metadata’ is shared
whilst protecting anonymity of individuals to avoid
possible breaches of privacy. Institutions or compan-
ies, for example those identified by genomics as the
source of an outbreak, could suffer financial losses or
reputational damage. Clearly, a careful balance needs
to be reached between these concerns and the evident
positive public health benefit of routine and rapid data
sharing.
Concluding remarks
We envisage a future of ubiquitous pathogen surveil-
lance, generated with ‘cheap as chips’ sequencing,
linked by the internet. Automated clustering algo-
rithms will be able to detect outbreaks far quicker
than traditional case-exceedance methods [13]. Port-
able genome sequencing will make it possible to sam-
ple the natural environment for pathogen reservoirs,
as well as clinical samples close to the patient. It is
our firm belief that these digital genomic data, gene-
rated by a diverse range of agents — and then shared
widely — will serve to break conventional silo thinking
about infections.
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